Pubblicazioni

A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata

2023 - ARCHIVES OF DERMATOLOGICAL RESEARCH

Mikhaylov, D.; Glickman, J. W.; Del Duca, E.; Nia, J.; Hashim, P.; Singer, G. K.; Posligua, A. L.; Florek, A. G.; Ibler, E.; Hagstrom, E. L.; Estrada, Y.; Rangel, S. M.; Colavincenzo, M.; Paller, A. S.; Guttman-Yassky, E.

Alopecia universalis occurring after alemtuzumab treatment for multiple sclerosis. A two-year follow-up of two patients

2021 - INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH

Borriello, Giovanna; Ianniello, Antonio; Toosy, Ahmed T